FI932032L - Kinazolinderivat foer oekande av antitumoeraktivitet - Google Patents
Kinazolinderivat foer oekande av antitumoeraktivitet Download PDFInfo
- Publication number
- FI932032L FI932032L FI932032A FI932032A FI932032L FI 932032 L FI932032 L FI 932032L FI 932032 A FI932032 A FI 932032A FI 932032 A FI932032 A FI 932032A FI 932032 L FI932032 L FI 932032L
- Authority
- FI
- Finland
- Prior art keywords
- quinazolinderivat
- oekande
- antitumoeractivitet
- foer
- quinazolinderivat foer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Preventing Corrosion Or Incrustation Of Metals (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60998690A | 1990-11-06 | 1990-11-06 | |
| PCT/US1991/007254 WO1992007844A1 (en) | 1990-11-06 | 1991-10-10 | Quinazolines derivatives for enhancing antitumor activity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI932032A0 FI932032A0 (fi) | 1993-05-05 |
| FI932032A7 FI932032A7 (fi) | 1993-05-05 |
| FI932032L true FI932032L (fi) | 1993-05-05 |
Family
ID=24443149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI932032A FI932032L (fi) | 1990-11-06 | 1991-10-10 | Kinazolinderivat foer oekande av antitumoeraktivitet |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US5444062A (cs) |
| EP (1) | EP0556310B1 (cs) |
| JP (1) | JPH05507290A (cs) |
| KR (1) | KR930702292A (cs) |
| CN (1) | CN1061411A (cs) |
| AT (1) | ATE124694T1 (cs) |
| BR (1) | BR9107070A (cs) |
| CA (1) | CA2095213A1 (cs) |
| CZ (1) | CZ400992A3 (cs) |
| DE (2) | DE9190155U1 (cs) |
| DK (1) | DK0556310T3 (cs) |
| ES (1) | ES2074867T3 (cs) |
| FI (1) | FI932032L (cs) |
| GR (1) | GR3017122T3 (cs) |
| HU (1) | HUT64533A (cs) |
| IE (1) | IE913854A1 (cs) |
| IL (1) | IL99906A0 (cs) |
| MX (1) | MX9101913A (cs) |
| NO (1) | NO931635D0 (cs) |
| NZ (1) | NZ240476A (cs) |
| PT (1) | PT99415A (cs) |
| SK (1) | SK400992A3 (cs) |
| WO (1) | WO1992007844A1 (cs) |
| YU (1) | YU47993B (cs) |
| ZA (1) | ZA918767B (cs) |
Families Citing this family (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2599992A (en) * | 1991-11-12 | 1993-06-15 | Pfizer Inc. | Triazine derivatives for enhancing antitumor activity |
| KR0144833B1 (ko) * | 1992-12-28 | 1998-07-15 | 김태훈 | 신규의 퀴나졸린 유도체 및 그의 제조방법 |
| IL112248A0 (en) | 1994-01-25 | 1995-03-30 | Warner Lambert Co | Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them |
| IL112249A (en) | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
| CN1058265C (zh) * | 1994-05-16 | 2000-11-08 | 株式会社柳韩洋行 | 喹唑啉衍生物,其制备方法及包含该物质的组合物 |
| JP2896532B2 (ja) * | 1994-08-13 | 1999-05-31 | ユーハン コーポレーション | 新規なピリミジン誘導体およびその製造方法 |
| EP0794178A4 (en) * | 1994-11-25 | 1998-02-25 | Nippon Chemiphar Co | CHINAZOLIN DERIVATIVES |
| TW334434B (en) * | 1995-05-16 | 1998-06-21 | Kanebo Ltd | Novel quinazoline compound and anti-tumor agent |
| WO1997020822A1 (en) * | 1995-12-01 | 1997-06-12 | Novartis Ag | Quinazolin-2,4-diazirines as npy receptor antagonist |
| AU7692996A (en) * | 1995-12-01 | 1997-06-27 | Ciba-Geigy Ag | Receptor antagonists |
| EA001595B1 (ru) * | 1996-04-12 | 2001-06-25 | Варнер-Ламберт Компани | Необратимые ингибиторы тирозинкиназ |
| IN188411B (cs) | 1997-03-27 | 2002-09-21 | Yuhan Corp | |
| US6184226B1 (en) | 1998-08-28 | 2001-02-06 | Scios Inc. | Quinazoline derivatives as inhibitors of P-38 α |
| KR100272471B1 (ko) | 1998-11-17 | 2000-11-15 | 김선진 | 신규의 피리미딘 유도체 및 그의 제조방법 |
| ES2209728T3 (es) * | 1999-08-06 | 2004-07-01 | F. Hoffmann-La Roche Ag | Tetrahidro-benzo(d)azepinas y su uso como antagonistas de receptores de glutamato metabotropico. |
| US6608053B2 (en) * | 2000-04-27 | 2003-08-19 | Yamanouchi Pharmaceutical Co., Ltd. | Fused heteroaryl derivatives |
| US6369222B1 (en) * | 2000-07-18 | 2002-04-09 | Hoffmann-La Roche Inc. | mGluR antagonists and a method for their synthesis |
| US6900226B2 (en) * | 2000-09-06 | 2005-05-31 | Hoffman-La Roche Inc. | Neuropeptide Y antagonists |
| PE20030008A1 (es) | 2001-06-19 | 2003-01-22 | Bristol Myers Squibb Co | Inhibidores duales de pde 7 y pde 4 |
| EP1432693A2 (en) | 2001-10-01 | 2004-06-30 | Taisho Pharmaceutical Co. Ltd. | Mch receptor antagonists |
| GB0130341D0 (en) * | 2001-12-19 | 2002-02-06 | Smithkline Beecham Plc | Compounds |
| WO2003055866A1 (en) * | 2001-12-21 | 2003-07-10 | Bayer Pharmaceuticals Corporation | Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents |
| EP1560816A1 (en) * | 2002-07-05 | 2005-08-10 | F. Hoffmann-La Roche Ag | Quinazoline derivatives |
| FR2845994B1 (fr) * | 2002-10-18 | 2006-05-19 | Servier Lab | Nouveaux derives de benzo[e][1,4]oxazino[3,2-g]isoindole substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| JP2006523638A (ja) * | 2003-04-16 | 2006-10-19 | エフ．ホフマン−ラ ロシュ アーゲー | キナゾリン化合物 |
| KR100557093B1 (ko) * | 2003-10-07 | 2006-03-03 | 한미약품 주식회사 | 다약제 내성 저해 활성을 갖는 테트라졸 유도체 및 그의제조방법 |
| CN101155787B (zh) | 2005-04-11 | 2010-11-24 | 弗·哈夫曼-拉罗切有限公司 | (3,4-二氢-喹唑啉-2-基)-茚满-1-基-胺 |
| CN101100466B (zh) | 2006-07-05 | 2013-12-25 | 天津和美生物技术有限公司 | 不可逆蛋白质酪氨酸磷酰化酶抑制剂及其制备和应用 |
| BR112012022868A2 (pt) | 2010-03-16 | 2018-06-05 | Merck Patent Gmbh | morfolinilquinazolinas |
| DE102010025786A1 (de) | 2010-07-01 | 2012-01-05 | Merck Patent Gmbh | Pyrazolochinoline |
| DE102010035744A1 (de) | 2010-08-28 | 2012-03-01 | Merck Patent Gmbh | Imidazolonylchinoline |
| US8673914B2 (en) | 2011-03-28 | 2014-03-18 | St. John's University | Use of phosphodiesterase inhibitors for treating multidrug resistance |
| DE102011118830A1 (de) | 2011-11-18 | 2013-05-23 | Merck Patent Gmbh | Morpholinylbenzotriazine |
| DE102013008118A1 (de) | 2013-05-11 | 2014-11-13 | Merck Patent Gmbh | Arylchinazoline |
| CN108042546B (zh) * | 2018-01-24 | 2020-10-09 | 浙江工业大学 | 吗啉基乙酰氨基苯并[d]氮杂*基喹唑啉类化合物在制备治疗宫颈癌药物中的应用 |
| CN108125960B (zh) * | 2018-01-24 | 2020-08-21 | 浙江工业大学 | 异丁酰氨基苯并[d]氮杂*基喹唑啉类化合物在制备治疗肺癌药物中的应用 |
| CN108276385B (zh) * | 2018-01-24 | 2019-12-06 | 浙江工业大学 | 异丁酰氨基喹唑啉类化合物及其制备与应用 |
| CN108125959B (zh) * | 2018-01-24 | 2019-12-31 | 浙江工业大学 | 二甲氧基苯氨基乙酰氨基喹唑啉类化合物在制备治疗白血病药物中的应用 |
| CN108276384B (zh) * | 2018-01-24 | 2019-12-06 | 浙江工业大学 | 乙酰氨基苯并[d]氮杂卓基喹唑啉类化合物及其制备与应用 |
| CN108324718B (zh) * | 2018-01-24 | 2020-10-09 | 浙江工业大学 | 环己基甲氧基甲酰氨基氯代苯并氮杂*基喹唑啉类化合物在治疗白血病药物中的应用 |
| CN108125962B (zh) * | 2018-01-24 | 2020-08-21 | 浙江工业大学 | 苯并[d]氮杂*基喹唑啉类化合物在制备治疗肺癌药物中的应用 |
| CN108295076B (zh) * | 2018-01-24 | 2020-05-22 | 浙江工业大学 | 丙酰氨基二甲氧基苯并[d]氮杂*基喹唑啉类在制备治疗肺癌药物中的应用 |
| CN108078994B (zh) * | 2018-01-24 | 2020-01-03 | 浙江工业大学 | 6-(2-吗啉基乙酰氨基)喹唑啉类化合物在制备治疗肺癌药物中的应用 |
| CN108164510B (zh) * | 2018-01-24 | 2020-08-21 | 浙江工业大学 | 氯乙酰氨基苯并[d]氮杂*基喹唑啉类化合物及其制备方法和应用 |
| CN108047206B (zh) * | 2018-01-24 | 2019-11-29 | 浙江工业大学 | 特戊酰氨基苯并[d]氮杂*基喹唑啉类化合物及制备和应用 |
| CN108014114B (zh) * | 2018-01-24 | 2020-08-21 | 浙江工业大学 | 氯乙酰氨基喹唑啉类化合物在制备治疗肺癌药物中的应用 |
| CN109251196B (zh) * | 2018-01-24 | 2020-11-13 | 浙江工业大学 | 氨基苯并[d]氮杂*基喹唑啉类化合物及其制备方法和应用 |
| CN108125958B (zh) * | 2018-01-24 | 2020-08-21 | 浙江工业大学 | 邻甲苯氨基乙酰氨基氯代苯并氮杂*基喹唑啉类化合物在制备治疗白血病药物中的应用 |
| CN108078993B (zh) * | 2018-01-24 | 2020-02-21 | 浙江工业大学 | 6-硝基喹唑啉类化合物在制备治疗肺癌药物中的应用 |
| CN108014113B (zh) * | 2018-01-24 | 2020-10-09 | 浙江工业大学 | 丁酰氨基二甲氧基苯并[d]氮杂*基喹唑啉类化合物在制备治疗宫颈癌药物中的应用 |
| CN108084162B (zh) * | 2018-01-24 | 2019-11-29 | 浙江工业大学 | 二甲氧基苯氨基乙酰氨基苯并[d]氮杂*基喹唑啉类化合物及制备和应用 |
| CN108129461B (zh) * | 2018-01-24 | 2020-08-21 | 浙江工业大学 | 苯甲酰氨基苯并[d]氮杂*基喹唑啉类化合物及制备和应用 |
| CN108250185B (zh) * | 2018-01-24 | 2020-08-21 | 浙江工业大学 | 6-(2-(邻甲苯氨基)乙酰氨基)喹唑啉类化合物及制备和应用 |
| CN108125961B (zh) * | 2018-01-24 | 2020-05-26 | 浙江工业大学 | 吗啉基乙酰氨基甲氧苯基苯并氮杂*基喹唑啉类化合物在制备治疗白血病药物中的应用 |
| CN108329300B (zh) * | 2018-01-24 | 2020-10-09 | 浙江工业大学 | 硝基苯并[d]氮杂*基喹唑啉类化合物及其制备方法和应用 |
| CN108078992B (zh) * | 2018-01-24 | 2020-08-21 | 浙江工业大学 | 特戊酰氨基二甲氧基苯并[d]氮杂*基喹唑啉类化合物在制备治疗白血病药物中的应用 |
| CN108324719B (zh) * | 2018-01-24 | 2020-08-21 | 浙江工业大学 | 邻甲苯氨基乙酰氨基甲氧苯基苯并氮杂*基喹唑啉类化合物在制备治疗宫颈癌药物中的应用 |
| CN108014116B (zh) * | 2018-01-24 | 2020-08-21 | 浙江工业大学 | 氨基二甲氧基苯并[d]氮杂*基喹唑啉类化合物在制备治疗肺癌药物中的应用 |
| CN108186649B (zh) * | 2018-01-24 | 2020-05-26 | 浙江工业大学 | 丙酰氨基氯代苯并[d]氮杂*基喹唑啉类在制备治疗白血病药物中的应用 |
| CN108276386B (zh) * | 2018-01-24 | 2020-10-09 | 浙江工业大学 | 环己基甲氧基甲酰氨基喹唑啉类化合物及制备和应用 |
| CN108078995B (zh) * | 2018-01-24 | 2020-01-03 | 浙江工业大学 | 苯甲酰氨基喹唑啉类化合物在制备治疗肺癌药物中的应用 |
| CN108143736B (zh) * | 2018-01-24 | 2020-08-21 | 浙江工业大学 | 丁酰氨基苯并[d]氮杂*基喹唑啉类在制备治疗肺癌药物中的应用 |
| CN108014115B (zh) * | 2018-01-24 | 2020-10-02 | 浙江工业大学 | 特戊酰氨基甲氧苯基苯并[d]氮杂*基喹唑啉类化合物在制备治疗肺癌药物中的应用 |
| CN108017621B (zh) * | 2018-01-24 | 2020-08-21 | 浙江工业大学 | 吗啉基乙酰氨基二甲氧基苯并[d]氮杂*基喹唑啉类化合物及制备和应用 |
| CN108245521B (zh) * | 2018-01-24 | 2020-01-03 | 浙江工业大学 | 二丙氨基乙酰氨基苯并氮杂*基喹唑啉类化合物在制备治疗白血病药物中的应用 |
| CN108309984B (zh) * | 2018-01-24 | 2020-02-21 | 浙江工业大学 | 丙酰氨基喹唑啉类化合物在制备治疗宫颈癌药物中的应用 |
| CN108324717B (zh) * | 2018-01-24 | 2020-08-21 | 浙江工业大学 | 特戊酰氨基氯代苯并[d]氮杂*基喹唑啉类化合物在制备治疗宫颈癌药物中的应用 |
| CN108129460B (zh) * | 2018-01-24 | 2020-10-09 | 浙江工业大学 | 甲氧苯基苯并[d]氮杂*基喹唑啉类化合物及制备和应用 |
| CN108117542B (zh) * | 2018-01-24 | 2019-12-24 | 浙江工业大学 | 丙酰氨基甲氧苯基苯并[d]氮杂卓基喹唑啉类化合物及制备和应用 |
| CN108033949B (zh) * | 2018-01-24 | 2019-11-29 | 浙江工业大学 | 6-(2-二丙氨基乙酰氨基)喹唑啉类化合物及制备和应用 |
| CN108329299B (zh) * | 2018-01-24 | 2020-08-21 | 浙江工业大学 | 丁酰氨基氯代苯并[d]氮杂*基喹唑啉类化合物及制备和应用 |
| CN108245520B (zh) * | 2018-01-24 | 2019-12-24 | 浙江工业大学 | 乙酰氨基喹唑啉类化合物在制备治疗肺癌药物中的应用 |
| CN108014112B (zh) * | 2018-01-24 | 2020-10-09 | 浙江工业大学 | 邻甲苯氨基乙酰氨基苯并[d]氮杂*基喹唑啉类化合物在制备治疗肺癌药物中的应用 |
| CN108245519B (zh) * | 2018-01-24 | 2020-02-21 | 浙江工业大学 | 丁酰氨基喹唑啉类化合物在制备治疗白血病药物中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE958197C (de) * | 1952-04-18 | 1957-02-14 | Dr Siegfried Skraup | Verfahren zur Herstellung von 2, 4-Diaminochinazolin |
| CH457460A (fr) * | 1966-06-20 | 1968-06-15 | Parke Davis & Co | Procédé de préparation de quinazolines |
| US3511836A (en) * | 1967-12-13 | 1970-05-12 | Pfizer & Co C | 2,4,6,7-tetra substituted quinazolines |
| US3635979A (en) * | 1969-09-29 | 1972-01-18 | Pfizer | Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines |
| GB1390014A (en) * | 1971-05-07 | 1975-04-09 | Koninklijke Pharma Fab Nv | Process for the preparation of carbocyclic fused pyrimidine derivatives |
| GB1383409A (en) * | 1972-09-09 | 1974-02-12 | Pfizer Ltd | Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them |
| US3956495A (en) * | 1973-10-30 | 1976-05-11 | Eli Lilly And Company | 2,4-Diaminoquinazolines as antithrombotic agents |
| FR2389614A1 (en) * | 1977-05-05 | 1978-12-01 | Synthelabo | Antihypertensive 2,4-di:amino-quinazoline(s) - prepd. from a 2-halo-4-amino-quinazoline and a secondary amine |
| US4098788A (en) * | 1977-06-20 | 1978-07-04 | Bristol-Myers Company | Process for preparing quinazolines |
| US4287341A (en) * | 1979-11-01 | 1981-09-01 | Pfizer Inc. | Alkoxy-substituted-6-chloro-quinazoline-2,4-diones |
| IL88507A (en) * | 1987-12-03 | 1993-02-21 | Smithkline Beckman Intercredit | 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them |
| IL89027A (en) * | 1988-01-29 | 1993-01-31 | Lilly Co Eli | Quinazoline derivatives, process for their preparation and fungicidal, insecticidal and miticidal compositions containing them |
| GB8910722D0 (en) * | 1989-05-10 | 1989-06-28 | Smithkline Beckman Intercredit | Compounds |
-
1991
- 1991-10-10 DK DK92900750.8T patent/DK0556310T3/da active
- 1991-10-10 DE DE9190155U patent/DE9190155U1/de not_active Expired - Lifetime
- 1991-10-10 CZ CS924009A patent/CZ400992A3/cs unknown
- 1991-10-10 US US08/050,047 patent/US5444062A/en not_active Expired - Lifetime
- 1991-10-10 HU HU9301314A patent/HUT64533A/hu unknown
- 1991-10-10 CA CA002095213A patent/CA2095213A1/en not_active Abandoned
- 1991-10-10 BR BR9107070A patent/BR9107070A/pt not_active Application Discontinuation
- 1991-10-10 AT AT92900750T patent/ATE124694T1/de active
- 1991-10-10 KR KR1019930701349A patent/KR930702292A/ko not_active Withdrawn
- 1991-10-10 JP JP92501815A patent/JPH05507290A/ja active Pending
- 1991-10-10 EP EP92900750A patent/EP0556310B1/en not_active Expired - Lifetime
- 1991-10-10 FI FI932032A patent/FI932032L/fi not_active Application Discontinuation
- 1991-10-10 WO PCT/US1991/007254 patent/WO1992007844A1/en not_active Ceased
- 1991-10-10 DE DE69111077T patent/DE69111077T2/de not_active Expired - Fee Related
- 1991-10-10 ES ES92900750T patent/ES2074867T3/es not_active Expired - Lifetime
- 1991-10-10 SK SK4009-92A patent/SK400992A3/sk unknown
- 1991-10-30 IL IL99906A patent/IL99906A0/xx unknown
- 1991-11-04 PT PT99415A patent/PT99415A/pt not_active Application Discontinuation
- 1991-11-04 MX MX9101913A patent/MX9101913A/es unknown
- 1991-11-05 CN CN91108479A patent/CN1061411A/zh active Pending
- 1991-11-05 IE IE385491A patent/IE913854A1/en unknown
- 1991-11-05 NZ NZ240476A patent/NZ240476A/en unknown
- 1991-11-05 ZA ZA918767A patent/ZA918767B/xx unknown
- 1991-11-05 YU YU176191A patent/YU47993B/sh unknown
-
1993
- 1993-05-05 NO NO931635A patent/NO931635D0/no unknown
-
1995
- 1995-08-16 GR GR950402241T patent/GR3017122T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9107070A (pt) | 1994-05-31 |
| US5444062A (en) | 1995-08-22 |
| PT99415A (pt) | 1992-09-30 |
| AU644035B2 (en) | 1993-12-02 |
| ZA918767B (en) | 1993-05-05 |
| HU9301314D0 (en) | 1993-09-28 |
| CN1061411A (zh) | 1992-05-27 |
| YU176191A (sh) | 1994-01-20 |
| FI932032A0 (fi) | 1993-05-05 |
| DE9190155U1 (de) | 1993-10-07 |
| GR3017122T3 (en) | 1995-11-30 |
| EP0556310B1 (en) | 1995-07-05 |
| WO1992007844A1 (en) | 1992-05-14 |
| CA2095213A1 (en) | 1992-05-07 |
| KR930702292A (ko) | 1993-09-08 |
| DE69111077D1 (de) | 1995-08-10 |
| IE913854A1 (en) | 1992-05-22 |
| CZ400992A3 (en) | 1993-12-15 |
| ATE124694T1 (de) | 1995-07-15 |
| FI932032A7 (fi) | 1993-05-05 |
| ES2074867T3 (es) | 1995-09-16 |
| JPH05507290A (ja) | 1993-10-21 |
| NO931635L (no) | 1993-05-05 |
| NZ240476A (en) | 1994-04-27 |
| SK400992A3 (en) | 1995-08-09 |
| HUT64533A (en) | 1994-01-28 |
| NO931635D0 (no) | 1993-05-05 |
| AU9059291A (en) | 1992-05-26 |
| DK0556310T3 (da) | 1995-08-21 |
| YU47993B (sh) | 1996-08-13 |
| DE69111077T2 (de) | 1995-11-02 |
| MX9101913A (es) | 1992-07-08 |
| IL99906A0 (en) | 1992-08-18 |
| EP0556310A1 (en) | 1993-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI930862L (fi) | En doseringsform foer tidsvarierande moenster av laekemedeloeverlaotelse | |
| FI930886A0 (fi) | Foerfarande foer hindrande av avstoetning av transplanterad vaevnad | |
| FI932032L (fi) | Kinazolinderivat foer oekande av antitumoeraktivitet | |
| FI930848A0 (fi) | Foerfarande foer separering av ilmenit | |
| FI923931L (fi) | Anordning foer granskning av insidan av en foergrenad roerlinje | |
| FI930736L (fi) | Foerfarande foer framstaellning av ramnos fraon ramnolipider | |
| FI930763A7 (fi) | Framstaellning av klordioxid fraon klorsyra | |
| FI930165L (fi) | Framstaellning av synnerligen aktiva tvaettmedelspartiklar | |
| FI925884A7 (fi) | Avlaegsning av signaldistorsion | |
| FI924569L (fi) | Foerfarande foer enantioselektiv framstaellning av fenylisoserinderivat | |
| FI924568L (fi) | Foerfarande foer stereoselektiv framstaellning av fenylisoserinderivat | |
| FI931355L (fi) | Fasoeverfoeringsmedierat foerfarande foer framstaellning av glukamidtvaettmedel | |
| FI925415L (fi) | Framstaellning av substituerade piperidiner | |
| FI925988L (fi) | Foerfarande foer framstaellning av b-laktamer | |
| FI925515L (fi) | Foerfarande foer framstaellning av alfa-2-interferonkristaller | |
| FI931354L (fi) | Hoegkatalytiskt foerfarande foer framstaellning av glukamidtvaettmedel | |
| FI925435A7 (fi) | Foerfarande foer beredning av en vattenloesning av natriumfoereningar | |
| FI924436A7 (fi) | Foerfarande foer tillverkning av expanderade polystyrenfolier | |
| FI931356A0 (fi) | Foerbaettrat katalytiskt foerfarande foer framstaellning av glukamidtvaettmedel | |
| FI925805A0 (fi) | Framstaellning av kompositmaterial | |
| FI924826L (fi) | Fettkompositioner innehaollande polyestrar av polyolfettsyror | |
| FI925609A0 (fi) | Foerfarande foer framstaellning av sykliska sulfater | |
| FI924371L (fi) | Foerfarande foer tillverkning av en elektromagnetisk omvandlare | |
| FI923776A7 (fi) | Foerfarande foer formning av pappersark | |
| FI924374L (fi) | Foerfarande foer dubbelsidig belaeggning av en roerlig materialbana |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |